Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Baroudjian

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annales De Dermatologie Et De Venereologie|May 7, 2025
Immune checkpoint inhibitors induced subcutaneous panniculitis-like T-cell lymphomaS Idoudi, A De Masson, C Gandon, et al.
Cancer Chemotherapy and Pharmacology|May 31, 2021
Dabrafenib and trametinib exposure-efficacy and tolerance in metastatic melanoma patients: a pharmacokinetic-pharmacodynamic real-life studyLauriane Goldwirt, B Louveau, B Baroudjian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 30, 2021
Clinical, biological and histological characteristics of bullous pemphigoid associated with anti-PD-1/PD-L1 therapy: A national retrospective studyC Juzot, V Sibaud, F Amatore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annales De Dermatologie Et De Venereologie|May 7, 2025
Immune checkpoint inhibitors induced subcutaneous panniculitis-like T-cell lymphomaS Idoudi, A De Masson, C Gandon, et al.
Cancer Chemotherapy and Pharmacology|May 31, 2021
Dabrafenib and trametinib exposure-efficacy and tolerance in metastatic melanoma patients: a pharmacokinetic-pharmacodynamic real-life studyLauriane Goldwirt, B Louveau, B Baroudjian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 30, 2021
Clinical, biological and histological characteristics of bullous pemphigoid associated with anti-PD-1/PD-L1 therapy: A national retrospective studyC Juzot, V Sibaud, F Amatore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Pageof 2